PharmaCog

18/12/2015		Final meeting of the PharmaCog Steering Committee
03/10/2015		PharmaCog researchers show progress at ECCN conference
28/06/2015		PharmaCog researchers show results at EACPT conference
25/02/2015		PharmaCog partners hold Steering Committee meeting
12/07/2014		PharmaCog partners at the AAIC conference
10/07/2013		PharmaCog researchers present findings at AAIC
03/06/2013		PharmaCog holds third General Assembly
11/05/2012		PharmaCog team holds annual review
01/04/2012		PharmaCog project team announces personnel changes
31/03/2012		Régis Bordet is the new Academic Coordinator for PharmaCog
28/02/2012		Alzheimer Europe holds 12th lunch debate at the European Parliament
16/01/2012		PharmaCog holds second Annual General Assembly
24/10/2011		Jean de Barry will lead Work Package 6 for PharmaCog
17/10/2011		PharmaCog project team holds progress meeting
30/10/2010		Information on the European “PharmaCog” project now available on Alzheimer Europe’s website

PharmaCog is short for “Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development”. It is a partnership of 32 academic and industry actors from 7 countries, co-ordinated by GlaxoSmithKline R&D and the Université de la Méditerranée, started its activities on January 1, 2010 thanks to significant funding (EUR 20.2 million) from the Innovative Medicines Initiative. Its launch marks the start of the most ambitious European project for tackling bottlenecks in Alzheimer's disease research and drug discovery.

PharmaCog will provide the tools needed to define more precisely the potential of a drug candidate, reduce the development time of new medicines and thus accelerate the approvals of promising new medicines.

Downloads

•   PharmaCog flyer May 2012
•   PharmaCog Executive Summary for Y5 report